A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Low-dose Lurasidone in Acutely Psychotic Subjects With Schizophrenia
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008672/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in
subjects with an acute exacerbation of schizophrenia.
提供机构：
Vivli
创建时间：
2022-12-15
